Skov-Stahl P, Norh S, Weeke B
Clin Exp Immunol. 1977 Mar;27(3):432-9.
Histamine release from leucocytes was demonstrated in grass pollen hay fever patients on in vitro challenge with extract of Pleum pratense (timothy). No release was found in persons without a history of grass pollen allergy. During preseasonal hyposensitization the following tendencies were found in cell sensitivity to allergen as well as in specific IgE antibody level of serum: an initial increase at the beginning of the therapy followed by a decrease during the pollen season. This is in contrast to untreated hay fever patients in whom an increase or no change at all of cell sensitivity and specific IgE was observed in the pollen season. Immunotherapy, therefore, can prevent such an increase in the pollen season. The mechanism might be due to a depression of the IgE production. In untreated as well as in treated patients the cell sensitivity was found to be significantly correlated to the grass specific IgE determined by RAST but not to the total serum level of IgE estimated by RIST. It seems likely that the sensitivity would be useful for evaluating the degree of allergy in grass pollen hay fever patients treated or not treated with immunotherapy.
对草花粉性干草热患者进行体外激发试验,用草地早熟禾(梯牧草)提取物激发,可证明白细胞释放组胺。在无草花粉过敏史的人身上未发现组胺释放。在季节性预防脱敏治疗期间,发现细胞对变应原的敏感性以及血清特异性IgE抗体水平有以下趋势:治疗开始时最初升高,随后在花粉季节降低。这与未经治疗的干草热患者形成对比,在这些患者中,花粉季节观察到细胞敏感性增加或根本没有变化,以及特异性IgE增加。因此,免疫疗法可以防止花粉季节出现这种增加。其机制可能是由于IgE产生受到抑制。在未经治疗和接受治疗的患者中,均发现细胞敏感性与通过放射性变应原吸附试验(RAST)测定的草特异性IgE显著相关,但与通过放射免疫扩散试验(RIST)估计的总血清IgE水平无关。细胞敏感性似乎有助于评估接受或未接受免疫疗法治疗的草花粉性干草热患者的过敏程度。